Pharmacology of ticarcillin combined with clavulanic acid in humans.
Serum and urine levels of ticarcillin and clavulanic acid after administration of doses of 50 mg/kg and 1.7 mg/kg or 50 mg/kg and 3 g/0.1 g, respectively, are potentially toxic to susceptible bacteria. Both compounds are widely distributed in body tissues and fluids, with concentrations exceeding the minimal inhibitory concentrations of most pathogens. Excretion is primarily renal, although there is some metabolism of clavulanate in the body. Due to accumulation, dosage adjustment is required for patients with renal insufficiency. Both ticarcillin and clavulanic acid are cleared by hemodialysis.
D019818:Clavulanic Acid; D002969:Clavulanic Acids / Q000008:administration & dosage / Q000378:metabolism*; D004338:Drug Combinations; D006801:Humans; D007674:Kidney Diseases / Q000378:metabolism; D007700:Kinetics; D010406:Penicillins / Q000378:metabolism*; D013982:Ticarcillin / Q000008:administration & dosage / Q000378:metabolism*; D014018:Tissue Distribution
D002969:Clavulanic Acids; D004338:Drug Combinations; D010406:Penicillins; D019818:Clavulanic Acid; D013982:Ticarcillin